Next Article in Journal
Dichotocejpins A–C: New Diketopiperazines from a Deep-Sea-Derived Fungus Dichotomomyces cejpii FS110
Previous Article in Journal
A Saponification Method for Chlorophyll Removal from Microalgae Biomass as Oil Feedstock
Open AccessArticle

The Brown Alga Stypopodium zonale (Dictyotaceae): A Potential Source of Anti-Leishmania Drugs

1
Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro 21.941-902, Brazil
2
Laboratório Produtos Naturais de Algas Marinhas (ALGAMAR), Departamento de Biologia Marinha, Instituto de Biologia, Universidade Federal Fluminense, Niterói 24.210-150, Brazil
3
Grupo de Produtos Naturais de Organismos Aquáticos (GPNOA), Núcleo em Ecologia e Desenvolvimento Sócioambiental de Macaé (NUPEM), Universidade Federal do Rio de Janeiro, Campus-Macaé, Rio de Janeiro 27.965-045, Brazil
*
Author to whom correspondence should be addressed.
Academic Editor: Keith B. Glaser
Mar. Drugs 2016, 14(9), 163; https://doi.org/10.3390/md14090163
Received: 5 August 2016 / Revised: 31 August 2016 / Accepted: 1 September 2016 / Published: 8 September 2016
This study evaluated the anti-Leishmania amazonensis activity of a lipophilic extract from the brown alga Stypopodium zonale and atomaric acid, its major compound. Our initial results revealed high inhibitory activity for intracellular amastigotes in a dose-dependent manner and an IC50 of 0.27 μg/mL. Due to its high anti-Leishmania activity and low toxicity toward host cells, we fractionated the lipophilic extract. A major meroditerpene in this extract, atomaric acid, and its methyl ester derivative, which was obtained by a methylation procedure, were identified by nuclear magnetic resonance (NMR) spectroscopy. Both compounds inhibited intracellular amastigotes, with IC50 values of 20.2 μM (9 μg/mL) and 22.9 μM (10 μg/mL), and selectivity indexes of 8.4 μM and 11.5 μM. The leishmanicidal activity of both meroditerpenes was independent of nitric oxide (NO) production, but the generation of reactive oxygen species (ROS) may be at least partially responsible for the amastigote killing. Our results suggest that the lipophilic extract of S. zonale may represent an important source of compounds for the development of anti-Leishmania drugs. View Full-Text
Keywords: marine natural products; meroditerpenes; Stypopodium zonale; leshmanicidal activity marine natural products; meroditerpenes; Stypopodium zonale; leshmanicidal activity
Show Figures

Figure 1

MDPI and ACS Style

Soares, D.C.; Szlachta, M.M.; Teixeira, V.L.; Soares, A.R.; Saraiva, E.M. The Brown Alga Stypopodium zonale (Dictyotaceae): A Potential Source of Anti-Leishmania Drugs. Mar. Drugs 2016, 14, 163.

AMA Style

Soares DC, Szlachta MM, Teixeira VL, Soares AR, Saraiva EM. The Brown Alga Stypopodium zonale (Dictyotaceae): A Potential Source of Anti-Leishmania Drugs. Marine Drugs. 2016; 14(9):163.

Chicago/Turabian Style

Soares, Deivid C.; Szlachta, Marcella M.; Teixeira, Valéria L.; Soares, Angelica R.; Saraiva, Elvira M. 2016. "The Brown Alga Stypopodium zonale (Dictyotaceae): A Potential Source of Anti-Leishmania Drugs" Mar. Drugs 14, no. 9: 163.

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop